Synchrony Medical, a respiratory care technology company and creator of the FDA-cleared LibAirtyâ„¢ Airway Clearance System, today announced that RELACS (Real Life Evaluation of the LibAirtyâ„¢ Airway ...
Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective ...
Highly symptomatic bronchiectasis patients have increased exacerbation risks, regardless of previous exacerbation history or disease severity. Current guidelines do not recommend preventive treatments ...
Panelists discuss how future bronchiectasis research will focus on precision medicine, identify treatable traits, and expand networks of Centers of Excellence to provide advanced care and clinical ...
CHAPEL HILL, N.C.--(BUSINESS WIRE)--Renovion Inc., a biopharmaceutical company focused on restoring lung health in patients with bronchiectasis and other lung diseases, announced that adult patient ...
September 10, 2012 (Vienna, Austria) — An easy-to-use 7-point scale to evaluate disease severity in patients with noncystic fibrosis bronchiectasis has been developed. In a validation study, the score ...
The American College of Chest Physicians (CHEST) has released a new clinical guideline on the management of adult bronchiectasis. Published in the journal CHEST, the guideline contains 13 ...
The color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented ...
An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that patients with the lung disease bronchiectasis also often display sensitivity to ...
CHAPEL HILL, N.C. & MIAMI--(BUSINESS WIRE)--Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for the treatment of ...
Bronchiectasis is independently associated with mortality risk among patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), Spanish research shows. The study authors say the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results